Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients

doi:10.3748/wjg.v18.i45.6651

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 45

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4531)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

421

HTML

3831

Figures (1-3)

148

Tables (1-2)

131

Sum=4531

Dec 7, 2012 (publication date) through May 1, 2024

Times Cited of This Article

Times Cited (69)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Dec 7, 2012; 18(45): 6651-6656
Published online Dec 7, 2012. doi: 10.3748/wjg.v18.i45.6651

Full Size Figure Download Figure

Figure 3 Kaplan-Meier survival curves for lysine specific demethylase 1 expression in hepatocellular carcinoma patients. A: The hepatocellular carcinoma patients with high lysine specific demethylase 1 (LSD1) expression showed significantly shorter disease-free survival (P < 0.001); B: Overall survival (P < 0.001) rates than those with low LSD1 expression.

Citation: Zhao ZK, Yu HF, Wang DR, Dong P, Chen L, Wu WG, Ding WJ, Liu YB. Overexpression of lysine specific demethylase 1 predicts worse prognosis in primary hepatocellular carcinoma patients. World J Gastroenterol 2012; 18(45): 6651-6656
URL: https://www.wjgnet.com/1007-9327/full/v18/i45/6651.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i45.6651